Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance (Q43275541)

18 November 2017

Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance (English)

1 reference

18 November 2017

0 references

1 reference

glycated hemoglobin

23 October 2023

Yaomin Hu

1

1 reference

18 November 2017

Wei Liu

2

1 reference

18 November 2017

Yawen Chen

3

1 reference

18 November 2017

Ming Zhang

4

1 reference

18 November 2017

Lihua Wang

5

1 reference

18 November 2017

Huan Zhou

6

1 reference

18 November 2017

Peihong Wu

7

1 reference

18 November 2017

Xiangyu Teng

8

1 reference

18 November 2017

Ying Dong

9

1 reference

18 November 2017

Jia wen Zhou

10

1 reference

18 November 2017

Hua Xu

11

1 reference

18 November 2017

Jun Zheng

12

1 reference

18 November 2017

Shengxian Li

13

1 reference

18 November 2017

Tao Tao

14

1 reference

18 November 2017

Yumei Hu

15

1 reference

18 November 2017

Yun Jia

16

1 reference

18 November 2017

17 September 2009

1 reference

18 November 2017

1 reference

18 November 2017

47

1 reference

18 November 2017

231-236

1 reference

18 November 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1007/s00592-009-0143-2

18 November 2017

0 references

cites work

Oral glucose tolerance test: indications and limitations

1 reference

https://api.crossref.org/works/10.1007%2FS00592-009-0143-2

The reproducibility and usefulness of the oral glucose tolerance test in screening for diabetes and other cardiovascular risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-009-0143-2

Variability of capillary plasma glucose in healthy individuals in repeated 75 g oral glucose tolerance tests.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-009-0143-2

Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-009-0143-2

Relationship of glycosylated hemoglobin to oral glucose tolerance. Implications for diabetes screening

21 January 2018

2 references

23 October 2023

https://opencitations.net/index/coci/api/v1/citations/10.2337/DIAB.37.1.60

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1007/S00592-009-0143-2

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1007/S00592-009-0143-2

Diagnostic accuracy of glycohemoglobin A1c (HbA1c) for postprandial hyperglycemia was equivalent to that of fasting blood glucose.

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1007/S00592-009-0143-2

Is the measurement of glycated hemoglobin A1c alone an efficient screening test for undiagnosed diabetes? Japan National Diabetes Survey.

2 references

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1007/S00592-009-0143-2

23 October 2023

https://opencitations.net/index/coci/api/v1/citations/10.1016/J.DIABRES.2006.09.015

Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1007/S00592-009-0143-2

Efficient cutoff points for three screening tests for detecting undiagnosed diabetes and pre-diabetes: an economic analysis

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1007/S00592-009-0143-2

HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1007/S00592-009-0143-2

HbA1c measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose: the Early Diabetes Intervention Program (EDIP).

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1007/S00592-009-0143-2

Comparison of ADA and WHO screening methods for diabetes mellitus in obese patients. American Diabetes Association.

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1007/S00592-009-0143-2

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1007/S00592-009-0143-2

Receiver operating characteristic analysis on fasting plasma glucose, HbA1c, and fructosamine on diabetes screening.

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1007/S00592-009-0143-2

The clinical implications of impaired glucose tolerance

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1007/S00592-009-0143-2

Utility of HbA(1c) levels for diabetes case finding in hospitalized patients with hyperglycemia

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1007/S00592-009-0143-2

Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies. The DECODE-study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis of Diagnostic Criteria in Europe

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1007/S00592-009-0143-2

Screening for diabetes in obese patients using the new diagnostic criteria

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1007/S00592-009-0143-2

Screening for type 2 diabetes

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1007/S00592-009-0143-2

A two-step strategy for identification of high-risk subjects for a clinical trial of prevention of NIDDM.

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1007/S00592-009-0143-2

Combined use of fasting plasma glucose and HbA1c predicts the progression to diabetes in Chinese subjects.

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1007/S00592-009-0143-2

Identifiers

DOI

10.1007/S00592-009-0143-2

1 reference

18 November 2017

1 reference